Amazon.com IncAWS becomes Novo Nordisk's preferred cloud provider and strategic AI partner, securing a major customer for its cloud and AI services.
Novo Nordisk has entered a strategic partnership with Amazon Web Services to enhance drug discovery using artificial intelligence and cloud technologies. The collaboration includes establishing a co-innovation hub in London that brings together AWS engineers, AI specialists, and Novo Nordisk's research and development teams to streamline the process of bringing new medicines to market. AWS becomes Novo Nordisk's preferred cloud provider and strategic AI partner, leveraging AWS's AI technologies to compress timelines from drug target identification to clinical trials. The partnership aims to modernize Novo Nordisk's operations and harness AI-driven innovations across its efforts in treating chronic diseases.
Amazon.com IncAWS becomes Novo Nordisk's preferred cloud provider and strategic AI partner, securing a major customer for its cloud and AI services.
Alphabet Inc Class C
Microsoft Corporation
ServiceNow Inc
Novo Nordisk A/SPartnership with AWS aims to accelerate drug discovery through AI, potentially improving R&D efficiency and pipeline.